About the Conference

The 42nd International Conference on Drug Discovery and Drug Delivery System will be held on September 15–16, 2025, in Paris, France, uniting global leaders in pharmaceutical sciences, biotechnology, and clinical research. This prestigious annual event continues its legacy as a premier platform for knowledge exchange, innovation, and collaboration across academia, industry, and regulatory sectors.

With the theme “Integrating AI, Nanotechnology, and Precision Medicine in Drug Discovery and Delivery,” the conference aims to spotlight transformative technologies reshaping the future of therapeutics. From AI-driven molecular design and computational pharmacology to smart nanocarriers and personalized delivery platforms, this year’s sessions will explore breakthroughs that bridge discovery science and clinical application.

Attendees will engage in high-level discussions through keynote lectures, technical sessions, panel debates, and interactive workshops. The conference offers unmatched networking opportunities, poster presentations, and a platform for emerging researchers to showcase novel ideas.

Set against the vibrant backdrop of Paris, the event invites participants to contribute to meaningful advancements in drug development and patient-centered care. Join us to exchange insights, forge collaborations, and be part of shaping the next era of pharmaceutical innovation.

Why to Attend the Conference

The 42nd International Conference on Drug Discovery and Drug Delivery System, scheduled for September 15–16, 2025, in Paris, France, offers a unique opportunity to immerse yourself in the future of pharmaceutical science and innovation. With the theme “Integrating AI, Nanotechnology, and Precision Medicine in Drug Discovery and Delivery,” the conference brings together pioneering minds from across the globe to explore next-generation strategies in therapeutics.

Attending this conference will empower participants to:

• Stay Ahead of Innovation – Gain firsthand insights into cutting-edge research and technologies shaping drug discovery and targeted delivery.

• Engage with Global Experts – Interact with world-renowned scientists, clinicians, regulators, and industry leaders driving change.

• Collaborate Across Disciplines – Foster interdisciplinary partnerships that bridge chemistry, biology, AI, nanotech, and personalized medicine.

• Enhance Your Career – Present your work, publish in proceedings, and gain recognition among an international audience.

• Explore Real-World Applications – Discover translational research and real-time case studies that link lab innovation to patient care.

Join us in the heart of Paris for two days of knowledge exchange, inspiration, and strategic networking—where science meets future-ready healthcare.

Who Can Attend

The 42nd International Conference on Drug Discovery and Drug Delivery System, taking place on September 15–16, 2025 in Paris, France, is designed for a diverse and multidisciplinary audience engaged in advancing therapeutic innovation. The event welcomes participants from academia, industry, clinical research, and regulatory bodies who are involved in the discovery, development, and delivery of pharmaceutical agents.

Target Audience Includes:

• Pharmaceutical Scientists & Drug Discovery Researchers

• Medicinal & Organic Chemists

• Clinical Pharmacologists & Toxicologists

• Formulation Scientists & Delivery System Engineers

• Biotechnologists & Molecular Biologists

• Nanotechnology & Biomedical Device Experts

• Artificial Intelligence & Computational Drug Design Specialists

• Regulatory Affairs Professionals & Policy Makers

• Healthcare Professionals & Clinical Trial Investigators

• Academicians, Postdoctoral Fellows, and Graduate Students

• Biopharmaceutical & CRO Industry Representatives

Whether you are a seasoned expert or an early-career researcher, this conference offers valuable insights into the integration of AI, nanotechnology, and precision medicine into modern drug development. Join us to expand your professional network, share your research, and contribute to shaping the future of patient-centric therapeutics.

Market Analysis Report

The global pharmaceutical landscape is undergoing a revolution—powered by AI, nanotechnology, and precision medicine. By 2025, the drug discovery and delivery systems market in Europe and developed countries is forecasted to reach over USD 600 billion, marking a CAGR of 7.8%.

Europe alone is projected to exceed USD 390 billion, driven by strong government support, rising chronic disease burden, and the rapid adoption of digital health tools. Meanwhile, North America leads in AI-driven drug discovery, with over 65% of global investments funneled into biotech-AI partnerships and next-gen delivery systems.

The drug delivery segment—including smart injectables, nano-carriers, and sustained-release platforms—is set to cross USD 250 billion, reflecting the demand for patient-centric, targeted therapies.